NASDAQ: LXEO

Lexeo Therapeutics Inc Stock Forecast, Predictions & Price Target

The consensus among 5 Wall Street analysts covering (NASDAQ: LXEO) stock is to Strong Buy LXEO stock.

Out of 5 analysts, 3 (60%) are recommending LXEO as a Strong Buy, 2 (40%) are recommending LXEO as a Buy, 0 (0%) are recommending LXEO as a Hold, 0 (0%) are recommending LXEO as a Sell, and 0 (0%) are recommending LXEO as a Strong Sell.

If you're new to stock investing, here's how to buy Lexeo Therapeutics stock.

(NASDAQ: LXEO) Lexeo Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.85%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.96%.

Lexeo Therapeutics's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast LXEO's revenue for 2027 to be $1,259,308,102, with the lowest LXEO revenue forecast at $1,259,308,102, and the highest LXEO revenue forecast at $1,259,308,102. On average, 1 Wall Street analysts forecast LXEO's revenue for 2028 to be $2,978,389,006, with the lowest LXEO revenue forecast at $2,978,389,006, and the highest LXEO revenue forecast at $2,978,389,006.

In 2029, LXEO is forecast to generate $4,497,186,050 in revenue, with the lowest revenue forecast at $4,497,186,050 and the highest revenue forecast at $4,497,186,050.

According to 5 Wall Street analysts that have issued a 1 year LXEO price target, the average LXEO price target is $21.20, with the highest LXEO stock price forecast at $24.00 and the lowest LXEO stock price forecast at $19.00.

On average, Wall Street analysts predict that Lexeo Therapeutics's share price could reach $21.20 by Mar 12, 2025. The average Lexeo Therapeutics stock price prediction forecasts a potential upside of 69.6% from the current LXEO share price of $12.50.

(NASDAQ: LXEO) forecast ROE is N/A, which is considered weak.